HOME › DRUGS › BESILESOMAB
ACTIVE SUBSTANCE / INN

BESILESOMAB

Brand name(s): Scintimun
EMA LISTED
APPLICATION WITHDRAWN
AUTHORISED
Osteomyelitis;Radionuclide Imaging
Radionuclide Imaging
ACTIVE SUBSTANCE
Besilesomab
REGULATORS
EMA
SPONSORS / MAH
CIS bio international, Telix Innovations
TOTAL APPLICATIONS
2
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ScintimunTelix InnovationsAuthorised11/01/2010Osteomyelitis;Radionuclide Imaging
ScintimunCIS bio internationalApplication withdrawnRadionuclide Imaging

FULL INTELLIGENCE ON BESILESOMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →